Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease
Identifieur interne : 000212 ( Pmc/Curation ); précédent : 000211; suivant : 000213Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease
Auteurs : Andreas Hartmann [France] ; Stéphane Hunot [France] ; Patrick P. Michel [France] ; Marie-Paule Muriel [France] ; Sheela Vyas [Royaume-Uni] ; Baptiste A. Faucheux [France] ; Annick Mouatt-Prigent [France] ; Hélène Turmel [France] ; Anu Srinivasan [États-Unis] ; Merle Ruberg [France] ; Gerard I. Evan [Royaume-Uni] ; Yves Agid [France] ; Etienne C. Hirsch [France]Source :
- Proceedings of the National Academy of Sciences of the United States of America [ 0027-8424 ] ; 2000.
Abstract
Caspase-3 is an effector of apoptosis in experimental
models of Parkinson's disease (PD). However, its potential role in the
human pathology remains to be demonstrated. Using caspase-3
immunohistochemistry on the postmortem human brain, we observed a
positive correlation between the degree of neuronal loss in
dopaminergic (DA) cell groups affected in the mesencephalon of PD
patients and the percentage of caspase-3-positive neurons in these cell
groups in control subjects and a significant decrease of
caspase-3-positive pigmented neurons in the substantia nigra pars
compacta of PD patients compared with controls that also could be
observed in an animal model of PD. This suggests that neurons
expressing caspase-3 are more sensitive to the pathological process
than those that do not express the protein. In addition, using an
antibody raised against activated caspase-3, the percentage of active
caspase-3-positive neurons among DA neurons was significantly higher in
PD patients than in controls. Finally, electron microscopy analysis in
the human brain and
Url:
PubMed: 10688892
PubMed Central: 16023
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000214
Links to Exploration step
PMC:16023Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Caspase-3: A vulnerability factor and final effector in
apoptotic death of dopaminergic neurons in
Parkinson's disease</title><author><name sortKey="Hartmann, Andreas" sort="Hartmann, Andreas" uniqKey="Hartmann A" first="Andreas" last="Hartmann">Andreas Hartmann</name><affiliation wicri:level="1"><nlm:aff id="N0x9ea9268.0xa03f080">Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris, France;</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris</wicri:regionArea></affiliation></author><author><name sortKey="Hunot, Stephane" sort="Hunot, Stephane" uniqKey="Hunot S" first="Stéphane" last="Hunot">Stéphane Hunot</name><affiliation wicri:level="1"><nlm:aff id="N0x9ea9268.0xa03f080">Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris, France;</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris</wicri:regionArea></affiliation></author><author><name sortKey="Michel, Patrick P" sort="Michel, Patrick P" uniqKey="Michel P" first="Patrick P." last="Michel">Patrick P. Michel</name><affiliation wicri:level="1"><nlm:aff id="N0x9ea9268.0xa03f080">Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris, France;</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris</wicri:regionArea></affiliation></author><author><name sortKey="Muriel, Marie Paule" sort="Muriel, Marie Paule" uniqKey="Muriel M" first="Marie-Paule" last="Muriel">Marie-Paule Muriel</name><affiliation wicri:level="1"><nlm:aff id="N0x9ea9268.0xa03f080">Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris, France;</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris</wicri:regionArea></affiliation></author><author><name sortKey="Vyas, Sheela" sort="Vyas, Sheela" uniqKey="Vyas S" first="Sheela" last="Vyas">Sheela Vyas</name><affiliation wicri:level="1"><nlm:aff wicri:cut="; and" id="N0x9ea9268.0xa03f080">Imperial Cancer Research Fund Laboratories, 44 Lincoln's Inn Field, London WC2A 3PX, United Kingdom</nlm:aff><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Imperial Cancer Research Fund Laboratories, 44 Lincoln's Inn Field, London WC2A 3PX</wicri:regionArea></affiliation></author><author><name sortKey="Faucheux, Baptiste A" sort="Faucheux, Baptiste A" uniqKey="Faucheux B" first="Baptiste A." last="Faucheux">Baptiste A. Faucheux</name><affiliation wicri:level="1"><nlm:aff id="N0x9ea9268.0xa03f080">Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris, France;</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris</wicri:regionArea></affiliation></author><author><name sortKey="Mouatt Prigent, Annick" sort="Mouatt Prigent, Annick" uniqKey="Mouatt Prigent A" first="Annick" last="Mouatt-Prigent">Annick Mouatt-Prigent</name><affiliation wicri:level="1"><nlm:aff id="N0x9ea9268.0xa03f080">Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris, France;</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris</wicri:regionArea></affiliation></author><author><name sortKey="Turmel, Helene" sort="Turmel, Helene" uniqKey="Turmel H" first="Hélène" last="Turmel">Hélène Turmel</name><affiliation wicri:level="1"><nlm:aff id="N0x9ea9268.0xa03f080">Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris, France;</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris</wicri:regionArea></affiliation></author><author><name sortKey="Srinivasan, Anu" sort="Srinivasan, Anu" uniqKey="Srinivasan A" first="Anu" last="Srinivasan">Anu Srinivasan</name><affiliation wicri:level="2"><nlm:aff id="N0x9ea9268.0xa03f080">IDUN Pharmaceuticals Inc., 11085 North Pines Road, La Jolla, CA 92037</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>IDUN Pharmaceuticals Inc., 11085 North Pines Road, La Jolla</wicri:cityArea></affiliation></author><author><name sortKey="Ruberg, Merle" sort="Ruberg, Merle" uniqKey="Ruberg M" first="Merle" last="Ruberg">Merle Ruberg</name><affiliation wicri:level="1"><nlm:aff id="N0x9ea9268.0xa03f080">Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris, France;</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris</wicri:regionArea></affiliation></author><author><name sortKey="Evan, Gerard I" sort="Evan, Gerard I" uniqKey="Evan G" first="Gerard I." last="Evan">Gerard I. Evan</name><affiliation wicri:level="1"><nlm:aff wicri:cut="; and" id="N0x9ea9268.0xa03f080">Imperial Cancer Research Fund Laboratories, 44 Lincoln's Inn Field, London WC2A 3PX, United Kingdom</nlm:aff><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Imperial Cancer Research Fund Laboratories, 44 Lincoln's Inn Field, London WC2A 3PX</wicri:regionArea></affiliation></author><author><name sortKey="Agid, Yves" sort="Agid, Yves" uniqKey="Agid Y" first="Yves" last="Agid">Yves Agid</name><affiliation wicri:level="1"><nlm:aff id="N0x9ea9268.0xa03f080">Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris, France;</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris</wicri:regionArea></affiliation></author><author><name sortKey="Hirsch, Etienne C" sort="Hirsch, Etienne C" uniqKey="Hirsch E" first="Etienne C." last="Hirsch">Etienne C. Hirsch</name><affiliation wicri:level="1"><nlm:aff id="N0x9ea9268.0xa03f080">Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris, France;</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">10688892</idno><idno type="pmc">16023</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC16023</idno><idno type="RBID">PMC:16023</idno><date when="2000">2000</date><idno type="wicri:Area/Pmc/Corpus">000214</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000214</idno><idno type="wicri:Area/Pmc/Curation">000212</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000212</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Caspase-3: A vulnerability factor and final effector in
apoptotic death of dopaminergic neurons in
Parkinson's disease</title><author><name sortKey="Hartmann, Andreas" sort="Hartmann, Andreas" uniqKey="Hartmann A" first="Andreas" last="Hartmann">Andreas Hartmann</name><affiliation wicri:level="1"><nlm:aff id="N0x9ea9268.0xa03f080">Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris, France;</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris</wicri:regionArea></affiliation></author><author><name sortKey="Hunot, Stephane" sort="Hunot, Stephane" uniqKey="Hunot S" first="Stéphane" last="Hunot">Stéphane Hunot</name><affiliation wicri:level="1"><nlm:aff id="N0x9ea9268.0xa03f080">Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris, France;</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris</wicri:regionArea></affiliation></author><author><name sortKey="Michel, Patrick P" sort="Michel, Patrick P" uniqKey="Michel P" first="Patrick P." last="Michel">Patrick P. Michel</name><affiliation wicri:level="1"><nlm:aff id="N0x9ea9268.0xa03f080">Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris, France;</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris</wicri:regionArea></affiliation></author><author><name sortKey="Muriel, Marie Paule" sort="Muriel, Marie Paule" uniqKey="Muriel M" first="Marie-Paule" last="Muriel">Marie-Paule Muriel</name><affiliation wicri:level="1"><nlm:aff id="N0x9ea9268.0xa03f080">Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris, France;</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris</wicri:regionArea></affiliation></author><author><name sortKey="Vyas, Sheela" sort="Vyas, Sheela" uniqKey="Vyas S" first="Sheela" last="Vyas">Sheela Vyas</name><affiliation wicri:level="1"><nlm:aff wicri:cut="; and" id="N0x9ea9268.0xa03f080">Imperial Cancer Research Fund Laboratories, 44 Lincoln's Inn Field, London WC2A 3PX, United Kingdom</nlm:aff><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Imperial Cancer Research Fund Laboratories, 44 Lincoln's Inn Field, London WC2A 3PX</wicri:regionArea></affiliation></author><author><name sortKey="Faucheux, Baptiste A" sort="Faucheux, Baptiste A" uniqKey="Faucheux B" first="Baptiste A." last="Faucheux">Baptiste A. Faucheux</name><affiliation wicri:level="1"><nlm:aff id="N0x9ea9268.0xa03f080">Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris, France;</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris</wicri:regionArea></affiliation></author><author><name sortKey="Mouatt Prigent, Annick" sort="Mouatt Prigent, Annick" uniqKey="Mouatt Prigent A" first="Annick" last="Mouatt-Prigent">Annick Mouatt-Prigent</name><affiliation wicri:level="1"><nlm:aff id="N0x9ea9268.0xa03f080">Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris, France;</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris</wicri:regionArea></affiliation></author><author><name sortKey="Turmel, Helene" sort="Turmel, Helene" uniqKey="Turmel H" first="Hélène" last="Turmel">Hélène Turmel</name><affiliation wicri:level="1"><nlm:aff id="N0x9ea9268.0xa03f080">Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris, France;</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris</wicri:regionArea></affiliation></author><author><name sortKey="Srinivasan, Anu" sort="Srinivasan, Anu" uniqKey="Srinivasan A" first="Anu" last="Srinivasan">Anu Srinivasan</name><affiliation wicri:level="2"><nlm:aff id="N0x9ea9268.0xa03f080">IDUN Pharmaceuticals Inc., 11085 North Pines Road, La Jolla, CA 92037</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>IDUN Pharmaceuticals Inc., 11085 North Pines Road, La Jolla</wicri:cityArea></affiliation></author><author><name sortKey="Ruberg, Merle" sort="Ruberg, Merle" uniqKey="Ruberg M" first="Merle" last="Ruberg">Merle Ruberg</name><affiliation wicri:level="1"><nlm:aff id="N0x9ea9268.0xa03f080">Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris, France;</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris</wicri:regionArea></affiliation></author><author><name sortKey="Evan, Gerard I" sort="Evan, Gerard I" uniqKey="Evan G" first="Gerard I." last="Evan">Gerard I. Evan</name><affiliation wicri:level="1"><nlm:aff wicri:cut="; and" id="N0x9ea9268.0xa03f080">Imperial Cancer Research Fund Laboratories, 44 Lincoln's Inn Field, London WC2A 3PX, United Kingdom</nlm:aff><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Imperial Cancer Research Fund Laboratories, 44 Lincoln's Inn Field, London WC2A 3PX</wicri:regionArea></affiliation></author><author><name sortKey="Agid, Yves" sort="Agid, Yves" uniqKey="Agid Y" first="Yves" last="Agid">Yves Agid</name><affiliation wicri:level="1"><nlm:aff id="N0x9ea9268.0xa03f080">Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris, France;</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris</wicri:regionArea></affiliation></author><author><name sortKey="Hirsch, Etienne C" sort="Hirsch, Etienne C" uniqKey="Hirsch E" first="Etienne C." last="Hirsch">Etienne C. Hirsch</name><affiliation wicri:level="1"><nlm:aff id="N0x9ea9268.0xa03f080">Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris, France;</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris</wicri:regionArea></affiliation></author></analytic><series><title level="j">Proceedings of the National Academy of Sciences of the United States of America</title><idno type="ISSN">0027-8424</idno><idno type="eISSN">1091-6490</idno><imprint><date when="2000">2000</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Caspase-3 is an effector of apoptosis in experimental
models of Parkinson's disease (PD). However, its potential role in the
human pathology remains to be demonstrated. Using caspase-3
immunohistochemistry on the postmortem human brain, we observed a
positive correlation between the degree of neuronal loss in
dopaminergic (DA) cell groups affected in the mesencephalon of PD
patients and the percentage of caspase-3-positive neurons in these cell
groups in control subjects and a significant decrease of
caspase-3-positive pigmented neurons in the substantia nigra pars
compacta of PD patients compared with controls that also could be
observed in an animal model of PD. This suggests that neurons
expressing caspase-3 are more sensitive to the pathological process
than those that do not express the protein. In addition, using an
antibody raised against activated caspase-3, the percentage of active
caspase-3-positive neurons among DA neurons was significantly higher in
PD patients than in controls. Finally, electron microscopy analysis in
the human brain and <italic>in vitro</italic> data suggest that caspase-3
activation precedes and is not a consequence of apoptotic cell
death in PD.</p></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id><journal-id journal-id-type="publisher-id">PNAS</journal-id><journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title><issn pub-type="ppub">0027-8424</issn><issn pub-type="epub">1091-6490</issn><publisher><publisher-name>The National Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">10688892</article-id><article-id pub-id-type="pmc">16023</article-id><article-id pub-id-type="publisher-id">040556597</article-id><article-id pub-id-type="publisher-id">5565</article-id><article-categories><subj-group subj-group-type="heading"><subject>Biological Sciences</subject><subj-group><subject>Neurobiology</subject></subj-group></subj-group></article-categories><title-group><article-title>Caspase-3: A vulnerability factor and final effector in
apoptotic death of dopaminergic neurons in
Parkinson's disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hartmann</surname><given-names>Andreas</given-names></name><xref ref-type="aff" rid="N0x9ea9268.0xa03f080">*</xref></contrib><contrib contrib-type="author"><name><surname>Hunot</surname><given-names>Stéphane</given-names></name><xref ref-type="aff" rid="N0x9ea9268.0xa03f080">*</xref></contrib><contrib contrib-type="author"><name><surname>Michel</surname><given-names>Patrick P.</given-names></name><xref ref-type="aff" rid="N0x9ea9268.0xa03f080">*</xref></contrib><contrib contrib-type="author"><name><surname>Muriel</surname><given-names>Marie-Paule</given-names></name><xref ref-type="aff" rid="N0x9ea9268.0xa03f080">*</xref></contrib><contrib contrib-type="author"><name><surname>Vyas</surname><given-names>Sheela</given-names></name><xref ref-type="aff" rid="N0x9ea9268.0xa03f080">†</xref></contrib><contrib contrib-type="author"><name><surname>Faucheux</surname><given-names>Baptiste A.</given-names></name><xref ref-type="aff" rid="N0x9ea9268.0xa03f080">*</xref></contrib><contrib contrib-type="author"><name><surname>Mouatt-Prigent</surname><given-names>Annick</given-names></name><xref ref-type="aff" rid="N0x9ea9268.0xa03f080">*</xref></contrib><contrib contrib-type="author"><name><surname>Turmel</surname><given-names>Hélène</given-names></name><xref ref-type="aff" rid="N0x9ea9268.0xa03f080">*</xref></contrib><contrib contrib-type="author"><name><surname>Srinivasan</surname><given-names>Anu</given-names></name><xref ref-type="aff" rid="N0x9ea9268.0xa03f080">‡</xref></contrib><contrib contrib-type="author"><name><surname>Ruberg</surname><given-names>Merle</given-names></name><xref ref-type="aff" rid="N0x9ea9268.0xa03f080">*</xref></contrib><contrib contrib-type="author"><name><surname>Evan</surname><given-names>Gerard I.</given-names></name><xref ref-type="aff" rid="N0x9ea9268.0xa03f080">†</xref></contrib><contrib contrib-type="author"><name><surname>Agid</surname><given-names>Yves</given-names></name><xref ref-type="aff" rid="N0x9ea9268.0xa03f080">*</xref></contrib><contrib contrib-type="author"><name><surname>Hirsch</surname><given-names>Etienne C.</given-names></name><xref ref-type="aff" rid="N0x9ea9268.0xa03f080">*</xref><xref ref-type="author-notes" rid="FN153">§</xref></contrib></contrib-group><aff id="N0x9ea9268.0xa03f080"><label>*</label>Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtrière, 47 Boulevard de l′Hôpital, 75013 Paris, France;<label>†</label>Imperial Cancer Research Fund Laboratories, 44 Lincoln's Inn Field, London WC2A 3PX, United Kingdom; and<label>‡</label>IDUN Pharmaceuticals Inc., 11085 North Pines Road, La Jolla, CA 92037</aff><author-notes><fn id="FN153"><label>§</label><p>To whom reprint requests should be addressed. E-mail:
<email>hirsch@ccr.jussieu.fr</email>.</p></fn><fn><p>Communicated by Jean-Pierre Changeux, Institut Pasteur, Paris,
France</p></fn></author-notes><pub-date pub-type="ppub"><day>14</day><month>3</month><year>2000</year></pub-date><pub-date pub-type="epub"><day>25</day><month>2</month><year>2000</year></pub-date><volume>97</volume><issue>6</issue><fpage>2875</fpage><lpage>2880</lpage><history><date date-type="received"><day>20</day><month>8</month><year>1999</year></date><date date-type="accepted"><day>20</day><month>12</month><year>1999</year></date></history><copyright-statement>Copyright © 2000, The National Academy of Sciences</copyright-statement><copyright-year>2000</copyright-year><abstract><p>Caspase-3 is an effector of apoptosis in experimental
models of Parkinson's disease (PD). However, its potential role in the
human pathology remains to be demonstrated. Using caspase-3
immunohistochemistry on the postmortem human brain, we observed a
positive correlation between the degree of neuronal loss in
dopaminergic (DA) cell groups affected in the mesencephalon of PD
patients and the percentage of caspase-3-positive neurons in these cell
groups in control subjects and a significant decrease of
caspase-3-positive pigmented neurons in the substantia nigra pars
compacta of PD patients compared with controls that also could be
observed in an animal model of PD. This suggests that neurons
expressing caspase-3 are more sensitive to the pathological process
than those that do not express the protein. In addition, using an
antibody raised against activated caspase-3, the percentage of active
caspase-3-positive neurons among DA neurons was significantly higher in
PD patients than in controls. Finally, electron microscopy analysis in
the human brain and <italic>in vitro</italic> data suggest that caspase-3
activation precedes and is not a consequence of apoptotic cell
death in PD.</p></abstract></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000212 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 000212 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Pmc
|étape= Curation
|type= RBID
|clé= PMC:16023
|texte= Caspase-3: A vulnerability factor and final effector in
apoptotic death of dopaminergic neurons in
Parkinson's disease
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i -Sk "pubmed:10688892" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonFranceV1
| This area was generated with Dilib version V0.6.29. |  |